GTAM
IQMD

Global Trust Asset Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Global Trust Asset Management’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$2K – 479
2022
Q3 		$2K Buy
+200
New +$2.01K ﹤0.01% 409

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Global Trust Asset Management's IQMD Position: Q4 2022 in Review

Global Trust Asset Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q4 2022, closing a stake of 200 shares — an estimated $2K sold.

Global Trust Asset Management first reported a position in IQMD in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 60 funds tracked by Wall St. Rank hold IQMD as of Q4 2022.

  • Global Trust Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Global Trust Asset Management sold 200 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2K.
  • Global Trust Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Global Trust Asset Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Global Trust Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.